Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Somatuline Autogel
Active Ingredient: Lanreotide 24.6%w/w
Dosage Form: Solution for injection
New Zealand Sponsor: New Zealand Medical & Scientific Limited
Manufacturers: Beaufour Ipsen Industrie, Dreux, France
Ipsen Pharma Biotech, Parc d’Activities du Plateau de Signes, Signes, France
Dated this 9th day of March 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).